The Centers for Medicare & Medicaid Services announced last week a revised repairs and replacement policy for the DMEPOS Competitive Bidding Program.

The revised policy continues to allow any Medicare-enrolled supplier to repair medically necessary, beneficiary-owned equipment when necessary to make the equipment serviceable. The policy now considers repair parts to include components that are needed to repair the base equipment, including batteries and tires.

Independa Inc. of San Diego last week announced plans for the Artemis platform of health, safety and activity sensors to complete its integrated telecare suite for the independent elderly and their professional or family caregivers. The platform had its debut at the 2011 mHealth Summit in National Harbor, Md. The company plans to launch Artemis early next year.

A federal judge has stopped California from implementing a 20 percent cut to the state's In-Home Support Services program. Judge Claudia A. Wilken of the U.S. District Court for the Northern District of California issued a temporary restraining order on Dec. 1 to stop the cuts until the court can hear a request for preliminary injunction. The state wants to cut $100 million for the program that provides in-home health services.

The 14th and final session of VGM’s Group’s “Ins & Outs of National Competitive Bidding Round 2 and How to Make Money in an Uncertain Environment” is scheduled for Jan. 30-31 in Atlanta. The day-and-a-half session is the last live seminar before the bid window opens. Cost for VGM members is $149; GAMES, ADMEA and AAHomecare Members, $199; and non-members, $249. Prices are per registration.

ArjoHuntleigh Inc., a global medical technology company focusing on the care of people with reduced mobility, last week launched a new, Illinois-based division for developing and distributing medical equipment to people in homecare settings.

ArjoHuntleigh Home Care will offer wide ranging HME products, including patient handling systems, hygiene systems, therapeutic surfaces, medical beds and treatments for lymphedema.

Invacare Corp. stock plunged last week after the FDA proposed a consent decree that would suspend some operations at the company’s headquarters and wheelchair plant in Ohio.

The stock (IVC) dropped 29 percent to close at $14.70 on Thursday after Invacare confirmed in a press release that it intends to enter into discussions with the FDA regarding terms of the decree. By mid-morning Friday, the stock had risen to $15.98.

Registration opened last week for Round 2 of competitive bidding. The program has now expanded into 91 additional metropolitan areas, after encompassing nine metropolitan areas in Round 1. This broad transformation of the HME industry poses serious challenges for providers. HomeCare Monday is conducting an online survey of providers who have patients within any of the areas included in Round 2 of Medicare’s competitive bidding program.